RU2017128652A - Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения - Google Patents

Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения Download PDF

Info

Publication number
RU2017128652A
RU2017128652A RU2017128652A RU2017128652A RU2017128652A RU 2017128652 A RU2017128652 A RU 2017128652A RU 2017128652 A RU2017128652 A RU 2017128652A RU 2017128652 A RU2017128652 A RU 2017128652A RU 2017128652 A RU2017128652 A RU 2017128652A
Authority
RU
Russia
Prior art keywords
hemostatic
orc
powder
additive
paste
Prior art date
Application number
RU2017128652A
Other languages
English (en)
Other versions
RU2696575C2 (ru
RU2017128652A3 (ru
Inventor
И-лан ВАН
Гуанхой ЧЖАН
Original Assignee
Этикон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48537032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2017128652(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Этикон, Инк. filed Critical Этикон, Инк.
Publication of RU2017128652A publication Critical patent/RU2017128652A/ru
Publication of RU2017128652A3 publication Critical patent/RU2017128652A3/ru
Application granted granted Critical
Publication of RU2696575C2 publication Critical patent/RU2696575C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surgical Instruments (AREA)

Claims (11)

1. Гемостатический материал, содержащий прессованный порошок окисленной регенерированной целлюлозы (ОРЦ), полученный путем измельчения в шаровой мельнице, содержащий частицы, имеющие средний коэффициент пропорциональности от 1 до 18, имеющие размер частиц больше чем 180 мкм и насыпную плотность после уплотнения, по меньшей мере, 0,44 г/см3.
2. Гемостатический материал по п. 1, причем указанный материал дополнительно содержит добавку, причем указанная добавка представляет собой карбоксиметилцеллюлозу (КМЦ), соль кальция, противоинфекционный агент, активатор гемостаза, желатин, коллаген или их комбинации.
3. Гемостатическая паста, содержащая гемостатический материал по п. 1 и физиологический раствор.
4. Гемостатическая паста по п.3, причем паста имеет вязкость более 10 000 Па*с.
5. Гемостатический материал по п. 1, причем указанный порошок имеет текучесть, по меньшей мере, 7,5 см/с.
6. Способ получения гемостатического материала по п. 1, включающий стадии:
помещения материала на основе ОРЦ в прессующее устройство; представляющее собой шаровую мельницу,
прессования материала на основе ОРЦ в порошок до тех пор, пока коэффициент пропорциональности указанного порошка не достигнет значения от 1 до 18.
7. Способ по п. 6, причем указанный материал ОРЦ представляет собой ткань ОРЦ, нетканый материал ОРЦ или материал ОРЦ, измельченный способом резки.
8. Способ по п. 6, дополнительно включающий стадию смешивания материала ОРЦ с добавкой, причем указанная добавка представляет собой КМЦ, соль кальция, противоинфекционный агент, активатор гемостаза, желатин, коллаген, физиологический раствор или их комбинации.
9. Способ лечения раны, включающий стадии приложения гемостатического порошка по п. 1 на рану пациента и/или в нее.
RU2017128652A 2012-05-25 2013-05-22 Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения RU2696575C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/480,842 US8815832B2 (en) 2012-05-25 2012-05-25 Oxidized regenerated cellulose hemostatic powders and methods of making
US13/480,842 2012-05-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014152706A Division RU2629199C2 (ru) 2012-05-25 2013-05-22 Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения

Publications (3)

Publication Number Publication Date
RU2017128652A true RU2017128652A (ru) 2019-02-04
RU2017128652A3 RU2017128652A3 (ru) 2019-05-28
RU2696575C2 RU2696575C2 (ru) 2019-08-05

Family

ID=48537032

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2014152706A RU2629199C2 (ru) 2012-05-25 2013-05-22 Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения
RU2017128652A RU2696575C2 (ru) 2012-05-25 2013-05-22 Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2014152706A RU2629199C2 (ru) 2012-05-25 2013-05-22 Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения

Country Status (16)

Country Link
US (2) US8815832B2 (ru)
EP (3) EP3466455B1 (ru)
JP (1) JP6165849B2 (ru)
KR (2) KR102131601B1 (ru)
CN (1) CN104321085B (ru)
AU (1) AU2013266416B2 (ru)
BR (2) BR112014029206B1 (ru)
CA (2) CA2874622C (ru)
DK (1) DK3466455T3 (ru)
ES (2) ES2906971T3 (ru)
IL (2) IL235549B (ru)
IN (1) IN2014DN09514A (ru)
MX (2) MX354596B (ru)
RU (2) RU2629199C2 (ru)
WO (1) WO2013177242A1 (ru)
ZA (1) ZA201409429B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011066471A1 (en) 2009-11-25 2011-06-03 Loma Linda University Medical Center Chitosan-based hemostatic textile
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
BR112017000844B1 (pt) * 2014-07-18 2020-12-15 Ethicon, Inc Material compósito de carboximetil celulose e método para a fabricação e uso do mesmo
US10183132B2 (en) 2014-09-11 2019-01-22 Ethicon Llc Methods and devices for co-delivery of liquid and powdered hemostats and sealants
CA3004272C (en) * 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates
AU2016350051B2 (en) 2015-11-08 2020-11-19 Ethicon, Inc. Hemostatic mixture of cellulose-based short and long fibers
RU2731371C2 (ru) * 2015-11-08 2020-09-02 Омрикс Биофармасьютикалс Лтд. Гемостатическая смесь коротких и длинных волокон на основе целлюлозы
US11413335B2 (en) * 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN107754005B (zh) * 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
KR102656226B1 (ko) * 2016-12-09 2024-04-09 한국생산기술연구원 칼슘 카르복시메틸 셀룰로오스 파우더 및 수용성 키토산 화합물 파우더를 포함하는 지혈 소재 및 그의 제조 방법
RU2660582C1 (ru) * 2017-07-12 2018-07-06 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Гемостатическое покрытие в форме порошка
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
US11007299B2 (en) 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
IL262716A (en) * 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
US11241386B2 (en) * 2019-02-13 2022-02-08 Biolife, L.L.C. Wound sealing powder
ES2961107T3 (es) 2019-07-12 2024-03-08 Cilag Gmbh Int Polvo hemostático
WO2021014357A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Collagen-based biomaterials for wound management
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions
KR20210052099A (ko) * 2019-10-31 2021-05-10 주식회사 삼양바이오팜 분말형 지혈제 조성물 및 이의 제조 방법
CN113117133B (zh) * 2019-12-31 2023-03-14 广州迈普再生医学科技股份有限公司 一种纤维聚集体及其制备方法和应用
CN113117132B (zh) * 2019-12-31 2022-11-22 广州迈普再生医学科技股份有限公司 一种可吸收膨胀式纳米短纤维粉状材料及其制备方法和应用
CN113117131B (zh) * 2019-12-31 2023-01-03 广州迈普再生医学科技股份有限公司 一种纳米纤维微球材料及其制备方法和应用
KR20230007378A (ko) * 2020-04-17 2023-01-12 보스톤 싸이엔티픽 싸이메드 인코포레이티드 지혈 조성물 및 관련 방법
RU2756316C1 (ru) * 2020-06-15 2021-09-29 Федеральное государственное бюджетное учреждение науки Байкальский институт природопользования Сибирского отделения Российской академии наук (БИП СО РАН) Местное гемостатическое антибактериальное средство, способ его получения и медицинское изделие на его основе
US20220023491A1 (en) 2020-07-21 2022-01-27 Ethicon, Inc. Hemostatic Composite Aggregate Materials Having Surface Enriched with Hemostatis
CN114681660B (zh) * 2020-12-31 2023-04-18 广州迈普再生医学科技股份有限公司 可吸收止血粉及其制备方法和应用
MX2023008169A (es) 2021-01-08 2023-09-12 Cilag Gmbh Int Polvo sellador biorreabsorbible.
US20240148933A1 (en) 2022-11-08 2024-05-09 Ethicon, Inc. Expandable hemostatic tablets comprising oxidized regenerated cellulose

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5696191A (en) 1989-09-18 1997-12-09 Kimberly-Clark Worldwide, Inc. Surface-segregatable compositions and nonwoven webs prepared therefrom
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
JP3287798B2 (ja) 1997-12-17 2002-06-04 レンゴー株式会社 球状セルロース微粒子の製造方法
RU2146264C1 (ru) * 1998-08-10 2000-03-10 Институт эколого-технологических проблем Способ получения высокоокисленной целлюлозы и высокоокисленная целлюлоза "биоакцеллин"
GB2354708B (en) 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
US6627749B1 (en) 1999-11-12 2003-09-30 University Of Iowa Research Foundation Powdered oxidized cellulose
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US6652840B1 (en) 2001-02-21 2003-11-25 Terence Prevendar Bleeding control and healing aid compositions and methods of use
US20030124087A1 (en) 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040265371A1 (en) * 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
DE602005022554D1 (de) 2004-01-30 2010-09-09 Ferrosan As Hämostatische sprays und zusammensetzungen
US20070141156A1 (en) * 2005-12-21 2007-06-21 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US20080027365A1 (en) 2006-06-01 2008-01-31 Huey Raymond J Hemostatic device with oxidized cellulose pad
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
JP5031054B2 (ja) * 2010-03-18 2012-09-19 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース及びこれを含む固形製剤
US10022410B2 (en) 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
WO2013039070A1 (ja) 2011-09-12 2013-03-21 グンゼ株式会社 親水性化セルロース繊維の製造方法
US9028851B2 (en) 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
BR112017000844B1 (pt) 2014-07-18 2020-12-15 Ethicon, Inc Material compósito de carboximetil celulose e método para a fabricação e uso do mesmo
CA3004272C (en) 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates

Also Published As

Publication number Publication date
IL261869A (en) 2018-10-31
EP4043042A1 (en) 2022-08-17
US9539358B2 (en) 2017-01-10
RU2014152706A (ru) 2016-07-20
RU2696575C2 (ru) 2019-08-05
EP3466455A1 (en) 2019-04-10
KR20150015517A (ko) 2015-02-10
MX354596B (es) 2018-03-12
DK3466455T3 (da) 2022-03-14
RU2629199C2 (ru) 2017-08-25
ZA201409429B (en) 2017-04-26
KR102254305B1 (ko) 2021-05-24
RU2017128652A3 (ru) 2019-05-28
BR112014029206A2 (pt) 2017-06-27
IL261869B (en) 2020-07-30
BR122019014998B1 (pt) 2020-01-28
MX358625B (es) 2018-08-28
CA3094664A1 (en) 2013-11-28
ES2906971T3 (es) 2022-04-21
MX2014014322A (es) 2015-02-12
IL235549B (en) 2020-03-31
JP2015517388A (ja) 2015-06-22
AU2013266416A1 (en) 2014-11-27
ES2702714T3 (es) 2019-03-05
AU2013266416B2 (en) 2016-03-24
EP3466455B1 (en) 2022-01-19
JP6165849B2 (ja) 2017-07-19
CN104321085A (zh) 2015-01-28
CA2874622A1 (en) 2013-11-28
US20140329769A1 (en) 2014-11-06
KR102131601B1 (ko) 2020-07-09
US8815832B2 (en) 2014-08-26
IN2014DN09514A (ru) 2015-07-17
KR20200085904A (ko) 2020-07-15
CA2874622C (en) 2021-03-09
EP2854882B1 (en) 2018-10-31
CN104321085B (zh) 2017-06-23
US20130316974A1 (en) 2013-11-28
IL235549A0 (en) 2015-01-29
CA3094664C (en) 2023-06-06
WO2013177242A1 (en) 2013-11-28
EP2854882A1 (en) 2015-04-08
BR112014029206B1 (pt) 2019-11-26

Similar Documents

Publication Publication Date Title
RU2017128652A (ru) Гемостатические порошки окисленной регенерированной целлюлозы и способы их получения
JP7114661B2 (ja) 圧密止血セルロース系凝集体
HRP20171249T1 (hr) Postupak, cijev i uređaj za pripremanje pripravka za zarastanje rana
RU2014103332A (ru) Никотинозамещающая цитизиновая оральная атомизируемая жидкость и способ ее получения
CN102578711A (zh) 一种用于卷烟过滤嘴的海藻酸钠微粒及过滤嘴香烟
EP3398459A1 (en) Non-combustion-type inhalation article
MX2020006214A (es) Composicion de implante seco y formulacion de implante acuoso inyectable.
WO2014171738A1 (ko) 하이드로겔 팩 조성물 및 이를 이용한 마스크 팩
EP2520316A3 (en) Thrombin isolated from blood and blood fractions
CN104479871A (zh) 一种可捏破的二氧化碳固体香料球及其在卷烟滤棒中的应用
CN103721291A (zh) 一种快速止血敷料的制备方法
CN110152054A (zh) 止血组合物及其制备方法
CN104524627B (zh) 高强度的羟基磷灰石骨水泥的制备方法
CN102379859A (zh) 一种包裹功能作用物混悬液的海藻酸盐软胶囊的制备方法
MX352601B (es) Matriz continua con particulas osteoconductoras dispersadas en ella, método para formarla y método para regenerar hueso con ella.
CN103127551A (zh) 异种脱细胞真皮基质微粒软组织填充剂及其制备方法
CN103387627A (zh) 一种用于制备水凝胶的部分中和的聚丙烯酸及其制备方法
CN102987564A (zh) 一种降低主流烟气中氨含量的卷烟滤棒添加剂及其制备和应用
CN107158448A (zh) 一种医用生物止血材料及其制备方法
CN103933601A (zh) 一种新型壳聚糖复合止血粉及其制备方法
CN103893204B (zh) 一种壳聚糖盐酸盐钙止血粉的制备方法
JP2015211810A (ja) 自己硬化型リン酸カルシウム組成物、該組成物を製造するためのキットおよび製造方法
Lovett et al. Assessment of the uptake of simulated viscous exudate by adhesive foam dressings
Reddersen et al. In-vitro-analysis of the fluid management by hydroactive wound dressings using a maceration model
Tadier et al. Cogrinding significance for calcium carbonate–calcium phosphate mixed cement. II. Effect on cement properties